BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32220701)

  • 1. Lyman-Kutcher-Burman normal tissue complication probability modeling for radiation-induced esophagitis in non-small cell lung cancer patients receiving proton radiotherapy.
    Wang Z; Chen M; Sun J; Jiang S; Wang L; Wang X; Sahoo N; Gunn GB; Frank SJ; Nguyen QN; Liao Z; Chang JY; Zhu XR; Zhang X
    Radiother Oncol; 2020 May; 146():200-204. PubMed ID: 32220701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive performance of different NTCP techniques for radiation-induced esophagitis in NSCLC patients receiving proton radiotherapy.
    Chen M; Wang Z; Jiang S; Sun J; Wang L; Sahoo N; Brandon Gunn G; Frank SJ; Xu C; Chen J; Nguyen QN; Chang JY; Liao Z; Ronald Zhu X; Zhang X
    Sci Rep; 2022 Jun; 12(1):9178. PubMed ID: 35655073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer.
    Chapet O; Kong FM; Lee JS; Hayman JA; Ten Haken RK
    Radiother Oncol; 2005 Nov; 77(2):176-81. PubMed ID: 16256230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of high-grade esophagitis after definitive three-dimensional conformal therapy, intensity-modulated radiation therapy, or proton beam therapy for non-small cell lung cancer.
    Gomez DR; Tucker SL; Martel MK; Mohan R; Balter PA; Lopez Guerra JL; Liu H; Komaki R; Cox JD; Liao Z
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):1010-6. PubMed ID: 22920974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal tissue complication probability model parameter estimation for xerostomia in head and neck cancer patients based on scintigraphy and quality of life assessments.
    Lee TF; Chao PJ; Wang HY; Hsu HC; Chang P; Chen WC
    BMC Cancer; 2012 Dec; 12():567. PubMed ID: 23206972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of acute radiation-induced esophagitis in non-small-cell lung cancer patients using the Lyman NTCP model.
    Zhu J; Zhang ZC; Li BS; Liu M; Yin Y; Yu JM; Luo LM; Shu HZ; De Crevoisier R
    Radiother Oncol; 2010 Dec; 97(3):449-54. PubMed ID: 21067834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model development of dose and volume predictors for esophagitis induced during chemoradiotherapy for lung cancer as a step towards radiobiological treatment planning.
    He R; Duggar WN; Yang CC; Vijayakumar S
    BMC Pulm Med; 2023 Oct; 23(1):379. PubMed ID: 37814254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric predictors and Lyman normal tissue complication probability model of hematological toxicity in cervical cancer patients with treated with pelvic irradiation.
    Wang D; Yin Y; Zhou Q; Li Z; Ma X; Yin Y; Li B; Bai T; Li D; Zhu J
    Med Phys; 2022 Jan; 49(1):756-767. PubMed ID: 34800297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTCP Models for Severe Radiation Induced Dermatitis After IMRT or Proton Therapy for Thoracic Cancer Patients.
    Palma G; Monti S; Conson M; Xu T; Hahn S; Durante M; Mohan R; Liao Z; Cella L
    Front Oncol; 2020; 10():344. PubMed ID: 32257950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complication probability models for radiation-induced heart valvular dysfunction: do heart-lung interactions play a role?
    Cella L; Palma G; Deasy JO; Oh JH; Liuzzi R; D'Avino V; Conson M; Pugliese N; Picardi M; Salvatore M; Pacelli R
    PLoS One; 2014; 9(10):e111753. PubMed ID: 25360627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive modelling for late rectal and urinary toxicities after prostate radiotherapy using planned and delivered dose.
    Ong ALK; Knight K; Panettieri V; Dimmock M; Tuan JKL; Tan HQ; Wright C
    Front Oncol; 2022; 12():1084311. PubMed ID: 36591496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer.
    D'Avino V; Palma G; Liuzzi R; Conson M; Doria F; Salvatore M; Pacelli R; Cella L
    Radiat Oncol; 2015 Apr; 10():80. PubMed ID: 25890376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal tissue complication probability of acute eyelids erythema following radiotherapy of head and neck cancers and skull-base tumors.
    Momeni N; Ali Boroomand M; Roozmand Z; Namiranian N; Hamzian N
    Phys Med; 2023 Aug; 112():102621. PubMed ID: 37329741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the Dose-Response Relationship for Ocular Pain after Radiotherapy of Head and Neck Cancers and Skull Base Tumors based on the LKB Radiobiological Model.
    Momeni N; Broomand MA; Roozmand Z; Hamzian N
    J Biomed Phys Eng; 2023 Oct; 13(5):411-420. PubMed ID: 37868939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy.
    Belderbos J; Heemsbergen W; Hoogeman M; Pengel K; Rossi M; Lebesque J
    Radiother Oncol; 2005 May; 75(2):157-64. PubMed ID: 15890421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTCP modelling and pulmonary function tests evaluation for the prediction of radiation induced pneumonitis in non-small-cell lung cancer radiotherapy.
    Tsougos I; Nilsson P; Theodorou K; Kjellén E; Ewers SB; Jarlman O; Lind BK; Kappas C; Mavroidis P
    Phys Med Biol; 2007 Feb; 52(4):1055-73. PubMed ID: 17264370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal tissue complication probability estimation by the Lyman-Kutcher-Burman method does not accurately predict spinal cord tolerance to stereotactic radiosurgery.
    Daly ME; Luxton G; Choi CY; Gibbs IC; Chang SD; Adler JR; Soltys SG
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2025-32. PubMed ID: 21531516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
    Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
    Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward personalized dose-prescription in locally advanced non-small cell lung cancer: Validation of published normal tissue complication probability models.
    Thor M; Deasy J; Iyer A; Bendau E; Fontanella A; Apte A; Yorke E; Rimner A; Jackson A
    Radiother Oncol; 2019 Sep; 138():45-51. PubMed ID: 31146070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation Dose to the Thoracic Vertebral Bodies Is Associated With Acute Hematologic Toxicities in Patients Receiving Concurrent Chemoradiation for Lung Cancer: Results of a Single-Center Retrospective Analysis.
    Barney CL; Scoville N; Allan E; Ayan A; DiCostanzo D; Haglund KE; Grecula J; Williams T; Xu-Welliver M; Otterson GA; Bazan JG
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):748-755. PubMed ID: 29413286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.